- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Privia Health Group EVP Sells Nearly 5,000 Shares
Edward Fargis, an executive vice president at the healthcare technology company, offloaded a portion of his stock holdings.
Mar. 11, 2026 at 12:34pm
Got story updates? Submit your updates here. ›
Privia Health Group, Inc. (NASDAQ:PRVA) Executive Vice President Edward Fargis sold 4,949 shares of the company's stock on March 9th. The shares were sold at an average price of $22.84, resulting in a total transaction value of $113,035.16. Following the sale, Fargis still directly owns 83,711 shares of Privia Health Group, valued at approximately $1.9 million.
Why it matters
Insider transactions, such as stock sales by company executives, can provide insights into management's views on a company's prospects. While a single transaction does not necessarily indicate a broader trend, it can be noteworthy when a senior leader reduces their ownership stake.
The details
Fargis' stock sale represented a 5.58% decrease in his direct ownership of Privia Health Group shares. The company, which provides technology and services to help independent physicians and medical groups, has seen its stock price fluctuate between $18.77 and $26.51 over the past 52 weeks.
- The stock sale took place on Monday, March 9th, 2026.
The players
Edward Fargis
Executive Vice President at Privia Health Group, Inc.
Privia Health Group, Inc.
A healthcare technology company that partners with independent physicians, medical groups and health systems to transform patient care delivery.
The takeaway
While the sale of nearly 5,000 shares by Privia Health Group's EVP may raise some questions, a single insider transaction does not necessarily indicate a broader trend or concern about the company's prospects. Investors will likely continue to monitor Privia Health Group's financial performance and any further changes in insider ownership.

